Long-term Survival in Hilar Cholangiocarcinoma also Possible in Unresectable Patients

BACKGROUND: Radical resection remains the only curative treatment for hilar cholangiocarcinoma (HCCA). Only a limited proportion of patients, however, are eligible for resection. The survival and prognostic factors of these patients are largely unknown. The aim of this study was to evaluate survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruys, Anthony T., van Haelst, Steven, Busch, Olivier R., Rauws, Erik A., Gouma, Dirk J., van Gulik, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414707/
https://www.ncbi.nlm.nih.gov/pubmed/22569746
http://dx.doi.org/10.1007/s00268-012-1638-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414707/
https://www.ncbi.nlm.nih.gov/pubmed/22569746
http://dx.doi.org/10.1007/s00268-012-1638-5

Ejemplares similares